Siemens says the FDA approved a 3D tomosynthesis option for its Mammomat Inspiration digital mammography device.
Siemens Healthcare (NYSE:SI) today said the FDA approved a new breast tomosynthesis option for its Mammomat Inspiration digital mammography device.
Here's a look at some of the top Wall Street stories for medical device companies this week: Diabetes: Valeritas sets terms for $75m IPO; New Siemens healthcare unit to start in May; Australia halts trading in GI Dynamics shares; Bayer aims to boost drugs sales, margins over next 3 years
Siemens is slated to launch its new healthcare business as soon as May, according to a pair of unnamed sources.
(Reuters) — Siemens (NYSE:SI) will house its German healthcare operations in a standalone unit in the form of a GmbH legal entity May 1, 2 sources with knowledge of the matter said.
Siemens says it's investigating a Chinese media report that its healthcare business inflated its numbers by citing faked contracts.
(Reuters) — Germany's Siemens said it's investigating a media report that it boosted sales figures of its healthcare equipment in China by creating fake contracts.
With fiscal 1st-quarter profits down nearly 13% at Siemens Healthcare, the German conglomerate shakes things up with a new management team.
Siemens CEO Joe Kaeser tells a German newspaper that the conglomerate will hold on to its healthcare business, squelching speculation about a Siemens Healthcare spinout.
Siemens resigns itself to another year of flat sales and deals its hearing aids business to private equity firm EQT for $2.7 billion.
(Reuters) - Siemens (NYSE:SI) resigned itself to another year of flat sales today after reporting that 1-off charges hit profits again in the 4th quarter, this time for wind turbines.